Cargando…

Polypill revisited – Unity in diversity

Detalles Bibliográficos
Autores principales:	Dan, Gheorghe-Andrei, Dobrev, Dobromir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452522/ https://www.ncbi.nlm.nih.gov/pubmed/32885032 http://dx.doi.org/10.1016/j.ijcha.2020.100607

Ejemplares similares

Facilitated electrical cardioversion: does the selection of the antiarrhythmic drug matter?
por: Dan, Gheorghe-Andrei, et al.
Publicado: (2019)

Highlights from the International Journal of Cardiology Heart & Vasculature: Heart failure, atrial fibrillation, coronary artery disease and myocardial infarction
por: Linz, Dominik, et al.
Publicado: (2019)

Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging
por: Dan, Gheorghe-Andrei, et al.
Publicado: (2018)

Prognostic value of biomarkers of impaired metabolism in heart failure patients with reduced ejection fraction
por: Ciuculete, Denisa Corina, et al.
Publicado: (2019)

C1q nephropathy- unity in diversity
por: Malleshappa, Pavan
Publicado: (2013)

Anaesthesiology in India: Remarkable unity in a vast diversity.….
por: Bajwa, Sukhminder Jit Singh
Publicado: (2020)

Polypill—Friend or Foe?
por: Rishi, Rakesh Kumar
Publicado: (2011)

Is Medical Unity Practical?
Publicado: (1902)

The Polypill: From Promise to Pragmatism
por: Huffman, Mark D.
Publicado: (2015)

In Search of Unity in Diversity
por: Muralidhara, Koteshwara
Publicado: (2022)

Conventional Troponin-I versus high-sensitivity troponin-T: Performance and incremental prognostic value in non-ST-elevation acute myocardial infarction patients with negative CK-MB based on a real-world multicenter cohort
por: Ammirati, Enrico, et al.
Publicado: (2018)

Bayesian network analyses in atrial fibrillation – A path to better therapies?()
por: Heijman, Jordi, et al.
Publicado: (2019)

Outcome of atrial fibrillation ablation in pulmonary hypertension: Is pulmonary hypertension a modifiable risk factor?
por: Linz, Dominik, et al.
Publicado: (2019)

Implantable cardioverter-defibrillator therapy in primary versus secondary prevention: Reliable prediction of appropriate therapies and mortality is still an unmet need
por: Tsuji, Yukiomi, et al.
Publicado: (2021)

A disproportional rise in the growing submission rate to International Journal of Cardiology Heart & Vasculature during the COVID‑19 pandemic
por: Linz, Dominik, et al.
Publicado: (2021)

Fat chance for POAF? Pericardial adipose tissue and the arrhythmogenic substrate for postoperative atrial fibrillation
por: Gawałko, Monika, et al.
Publicado: (2022)

Recent highlights on the prevalence and role of sleep disordered breathing in cardiovascular diseases from the International Journal of Cardiology Heart & Vasculature
por: Linz, Dominik, et al.
Publicado: (2023)

Medical Unity in New York
Publicado: (1905)

Progress toward Medical Unity
Publicado: (1903)

The Conference Committees on Medical Unity
Publicado: (1902)

Repurposing traditional immunomodulators to target the inflammatory burden of atherosclerosis()
por: Fender, Anke C., et al.
Publicado: (2020)

Contemporary plaque imaging for risk stratification of coronary artery disease: Are we getting there?
por: Fender, Anke C., et al.
Publicado: (2020)

Pleiotropic actions of ticagrelor versus clopidogrel – Do molecular differences translate into superior clinical efficacy after myocardial infarction?
por: Fender, Anke C., et al.
Publicado: (2020)

Breaking bad: Higher risk of osteoporosis with vitamin K antagonists compared to direct oral anticoagulants in patients with atrial fibrillation
por: Fender, Anke C., et al.
Publicado: (2020)

Bound to bleed: How altered albumin binding may dictate warfarin treatment outcome
por: Fender, Anke C., et al.
Publicado: (2019)

Anticoagulation in difficult settings RELOADed: Evidence for applicability of direct oral anticoagulants in patients with atrial fibrillation, renal impairment and cancer
por: Fender, Anke C., et al.
Publicado: (2019)

Coronary clot composition after myocardial infarction: Thrombus age matters
por: Fender, Anke C., et al.
Publicado: (2019)

The virtual patient – Estimating the health utility of aspirin in simulated populations
por: Fender, Anke C., et al.
Publicado: (2021)

Childhood infection and modern malnutrition: Do childhood infections create an inflammatory foundation for atherosclerosis in adult life?
por: Fender, Anke C., et al.
Publicado: (2021)

Soluble fibrin monomer complex as a candidate sentinel for adverse events in patients with heart failure
por: Fender, Anke C., et al.
Publicado: (2021)

The temporal context of oral anticoagulation outcome in atrial fibrillation
por: Fender, Anke C., et al.
Publicado: (2022)

Evolving insights into the pleiotropic cardioprotective mechanisms of SGLT2 inhibitors
por: Fender, Anke C., et al.
Publicado: (2023)

Recent highlights from the International Journal of Cardiology Heart & Vasculature on challenges for adequate stroke prevention in patients with atrial fibrillation
por: Fender, Anke C., et al.
Publicado: (2023)

Recent highlights on specific aspects of oral anticoagulation in difficult clinical scenarios from the International Journal of Cardiology Heart & Vasculature
por: Fender, Anke C., et al.
Publicado: (2023)

Recent highlights on the mechanistic basis of cardiovascular remodeling from the International Journal of Cardiology Heart & Vasculature
por: Fender, Anke C., et al.
Publicado: (2023)

Can cystatin C-based estimated glomerular filtration rate help to guide individualized risk factor modification programs?
por: Linz, Dominik, et al.
Publicado: (2018)

Genome-wide association studies of atrial fibrillation: Finding meaning in the life of risk loci
por: Sutanto, Henry, et al.
Publicado: (2019)

Gut-microbiota derived TMAO: A risk factor, a mediator or a bystander in the pathogenesis of atrial fibrillation?
por: Gawałko, Monika, et al.
Publicado: (2021)

Does weight matter in cryoballoon ablation?
por: Gawałko, Monika, et al.
Publicado: (2023)

Altered Atrial Metabolism: An Underappreciated Contributor to the Initiation and Progression of Atrial Fibrillation
por: Ghezelbash, Shokoufeh, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tl76n2712tgohppih0pjt6hq9j